Company Filing History:
1 out of 832,843 Years Active: 2019
Title: Zrinka Abramovic: Innovator in Pharmaceutical Chemistry
Introduction
Zrinka Abramovic is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel hydrates of dolutegravir sodium. Her work is crucial in the fight against retroviral infections, including HIV-1.
Latest Patents
Zrinka Abramovic holds 1 patent for her invention titled "Hydrates of dolutegravir sodium." This invention relates to novel hydrates of dolutegravir sodium and processes for their preparation. It also introduces a new crystalline form of dolutegravir sodium, which serves as a useful intermediate for creating one of the novel hydrates. Furthermore, the invention discusses the use of these hydrates in producing pharmaceutical compositions, including oral dosage forms for treating retroviral infections.
Career Highlights
Throughout her career, Zrinka has worked with prominent companies in the pharmaceutical industry, including Lek Pharmaceuticals D.d. Her expertise in pharmaceutical chemistry has positioned her as a valuable asset in her field.
Collaborations
Zrinka has collaborated with notable professionals such as Andreas Hotter and Andrea Thaler, enhancing her research and development efforts in pharmaceutical innovations.
Conclusion
Zrinka Abramovic's contributions to pharmaceutical chemistry, particularly through her patent on dolutegravir sodium hydrates, highlight her role as an innovator in the industry. Her work continues to impact the development of effective treatments for retroviral infections.